Skip to main content
Clinical Trials/NCT04681625
NCT04681625
Completed
Not Applicable

Randomised Intervention Multicentre Study to Evaluate the Effect of Pelvic Floor Muscle Training in Men With BPH and OAB Treated With Silodosin - The SILODOSING Study

Comenius University1 site in 1 country172 target enrollmentJanuary 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Benign Prostatic Hyperplasia (BPH)
Sponsor
Comenius University
Enrollment
172
Locations
1
Primary Endpoint
Change in the number of voidings and intensity of urgencies during 24 hours using a micturition diary.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will evaluate the efficacy of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder treated with Silodosin.

Detailed Description

This is a randomised-intervention, parallel, multicentre study which will evaluate the efficacy of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder treated with silodosin.

Registry
clinicaltrials.gov
Start Date
January 11, 2021
End Date
September 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Comenius University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in the number of voidings and intensity of urgencies during 24 hours using a micturition diary.

Time Frame: over 12 weeks of treatment

The investigators will compare change in the number of voidings and the intensity of urgencies during 24 hours in the combined silodosin and pelvic floor muscle training to silodosin treatment alone.

Secondary Outcomes

  • Change in patient global impression of improvement(over 12 weeks of treatment)
  • Change in incontinence quality of life .(over 12 weeks of treatment)
  • Incidence of adverse events .(over 12 weeks of treatment)
  • Change in lower urinary tract symptoms.(over 12 weeks of treatment)

Study Sites (1)

Loading locations...

Similar Trials